Home » Topics » BioWorld MedTech

BioWorld MedTech
RSS

HDL PROTECTS AGAINST ATHEROSCLOROSIS

Sep. 19, 1991

COLLAGEN HOPES TO IMPLANT CONFIDENCE

Sep. 18, 1991

PHASE III TRIALS OF HEPATITIS TREATMENT

Sep. 18, 1991

PRIVATE PLACEMENT FUNDS TSI RESEARCH

Sep. 18, 1991

POSITIVE RESULTS IN WOUND-HEALING TESTS

Sep. 18, 1991

IDEC RAISES $45 MILLION IN IPO

Sep. 18, 1991

EPITOPE RAISES $7.3 MILLION IN EUROPE

Sep. 18, 1991

OK SOUGHT FOR VEGETABLE OIL TRIALS

Sep. 18, 1991

SIBIA SIGNS DEALS WITH UC FOR INHIBITORS

Sep. 17, 1991

UNIVAX CRADA FOR AIDS VACCINE

Sep. 17, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...